MedPath

Effect of adding dexmedetomidine to local anaesthetic wound infiltration for post surgery pain relief

Phase 1
Not yet recruiting
Conditions
Other intraoperative and postprocedural complications and disorders of digestive system,
Registration Number
CTRI/2019/02/017736
Lead Sponsor
Svims
Brief Summary

An incision made in the abdominal wall contributes to severe postoperative pain which may cause the decreased function of the immune system, decreased healing and painful suffering, these changes may probably negatively affect the postoperative recovery pain.

Wound infiltration with local anesthetics is one of the multimodal approaches to control postoperative pain after open abdominal surgeries.

Ropivacaine is a long-acting amide– local anesthetic, s-enantiomer mainly used for surgery and postoperative pain relief.4 At high doses, it produces surgical anesthesia and at lower doses, it produces analgesia mainly sensory block with a limited and non-progressive motor block. Ropivacaine has a slightly prolonged duration of action than bupivacaine and less cardiotoxic effects.

Dexmedetomidine is a strong and highly selective α2-adrenoreceptor agonist which has sedative, analgesic, and sympatholytic properties. It enhances the analgesic efficacy of local anesthetics when added as an adjuvant for wound infiltration.

Different doses of dexmedetomidine has been tried as adjuvant to local anaesthetics to prolong post operative analgesia.6,7,8However the optimum dose of dexmedetomidine is yet to be

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria
  • 1.Patients scheduled to undergo elective open abdominal surgeries at SVIMS.
  • 2.Patients belonging to ASA physical status 1,2 and 3.
  • 3.Age group between 18 and 65 years.
Exclusion Criteria
  • 1.Patient refusal to participate in the study.
  • 2.Severe hepatic/cardiac/renal disorders.
  • 3.Pre existing neurological deficits/psychiatric illness/metabolic disorders.
  • 5.History of chronic analgesic usage(on oral analgesics for more than one month).
  • 6.Pregnant and lactating mothers.
  • 7.Patients who cannot understand and interpret NRS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The magnitude of pain using NRS at fixed time intervalAt 0hr,2hr,4hr,6hr,12hr&24hr.
Secondary Outcome Measures
NameTimeMethod
Analgesic requirement in first 24 hours after surgery.The time to the first request of rescue analgesia.

Trial Locations

Locations (1)

svims

🇮🇳

Chittoor, ANDHRA PRADESH, India

svims
🇮🇳Chittoor, ANDHRA PRADESH, India
DrSumadhu
Principal investigator
9177704349
sumadhu13121991@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.